Section Arrow
LIVN.NASDAQ
- LivaNova PLC
Quotes are at least 15-min delayed:2026/06/21 07:33 EDT
Regular Hours
Last
 78.5
0 (0.00%)
Day High 
80.45 
Prev. Close
78.5 
1-M High
80.955 
Volume 
1.43M 
Bid
31.86
Ask
84
Day Low
77.71 
Open
79.66 
1-M Low
70.39 
Market Cap 
4.31B 
Currency 美元 
P/E 40.05 
%Yield -- 
10-SMA 77.34 
20-SMA 75.46 
50-SMA 69.67 
52-W High 80.955 
52-W Low 41.015 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.96/4.59
Enterprise Value
4.71B
Balance Sheet
Book Value Per Share
22.05
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
1.39B
Operating Revenue Per Share
20.36
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BFLYButterfly Network8.9+3.19+55.87%-- 
ABTAbbott Laboratories88.41-0.09-0.10%24.76PE
TNONTenon Medical Inc0.35-0.2521-41.87%-- 
BSXBoston Scientific Corp45.29+0.34+0.76%18.95PE
MDTMedtronic plc79.34+1.2+1.54%22.16PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.